-
Je něco špatně v tomto záznamu ?
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction
P. Fencl, O. Belohlavek, T. Harustiak, M. Zemanova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NT12331
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 2000-01-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2016-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do 2017-12-31
Health & Medicine (ProQuest)
od 2000-01-01 do 2017-12-31
- MeSH
- adenokarcinom farmakoterapie patologie chirurgie MeSH
- adjuvantní chemoterapie MeSH
- dospělí MeSH
- fluorodeoxyglukosa F18 MeSH
- gastroezofageální junkce patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymfatické metastázy diagnostické zobrazování patologie MeSH
- nádory jícnu farmakoterapie patologie chirurgie MeSH
- neoadjuvantní terapie MeSH
- PET/CT * MeSH
- prospektivní studie MeSH
- radiofarmaka MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: The aim of the analysis was to assess the accuracy of various FDG-PET/CT parameters in staging lymph nodes after neoadjuvant chemotherapy. METHODS: In this prospective study, 74 patients with adenocarcinoma of the esophageal-gastric junction were examined by FDG-PET/CT in the course of their neoadjuvant chemotherapy given before surgical treatment. Data from the final FDG-PET/CT examinations were compared with the histology from the surgical specimens (gold standard). The accuracy was calculated for four FDG-PET/CT parameters: (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes. RESULTS: In 74 patients, a total of 1540 lymph nodes were obtained by surgery, and these were grouped into 287 regions according to topographic origin. Five hundred and two nodes were imaged by FDG-PET/CT and were grouped into these same regions for comparison. In the analysis, (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes identified metastases in particular regions with sensitivities of 11.6%, 2.9%, 21.7%, and 13.0%, respectively; specificity was 98.6%, 94.5%, 74.8%, and 93.6%, respectively. The best accuracy of 77.7% reached the parameter of hypermetabolic nodes. Accuracy decreased to 62.0% when also smaller nodes (medium-large) were taken for the parameter of metastases. CONCLUSIONS: FDG-PET/CT proved low sensitivity and high specificity. Low sensitivity was based on low detection rate (32.6%) when compared nodes imaged by FDG-PET/CT to nodes found by surgery, and in inability to detect micrometastases. Sensitivity increased when also medium-large LNs were taken for positive, but specificity and accuracy decreased.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011120
- 003
- CZ-PrNML
- 005
- 20181213111648.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00261-016-0820-x $2 doi
- 035 __
- $a (PubMed)27405645
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fencl, Pavel, $u PET Center, Hospital Na Homolce, Roentgenova 2, 150 30, Prague 5, Czech Republic. pavel.fencl@homolka.cz. $d 1946- $7 xx0074214
- 245 10
- $a FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction / $c P. Fencl, O. Belohlavek, T. Harustiak, M. Zemanova,
- 520 9_
- $a OBJECTIVES: The aim of the analysis was to assess the accuracy of various FDG-PET/CT parameters in staging lymph nodes after neoadjuvant chemotherapy. METHODS: In this prospective study, 74 patients with adenocarcinoma of the esophageal-gastric junction were examined by FDG-PET/CT in the course of their neoadjuvant chemotherapy given before surgical treatment. Data from the final FDG-PET/CT examinations were compared with the histology from the surgical specimens (gold standard). The accuracy was calculated for four FDG-PET/CT parameters: (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes. RESULTS: In 74 patients, a total of 1540 lymph nodes were obtained by surgery, and these were grouped into 287 regions according to topographic origin. Five hundred and two nodes were imaged by FDG-PET/CT and were grouped into these same regions for comparison. In the analysis, (1) hypermetabolic nodes, (2) large nodes, (3) large-and-medium large nodes, and (4) hypermetabolic or large nodes identified metastases in particular regions with sensitivities of 11.6%, 2.9%, 21.7%, and 13.0%, respectively; specificity was 98.6%, 94.5%, 74.8%, and 93.6%, respectively. The best accuracy of 77.7% reached the parameter of hypermetabolic nodes. Accuracy decreased to 62.0% when also smaller nodes (medium-large) were taken for the parameter of metastases. CONCLUSIONS: FDG-PET/CT proved low sensitivity and high specificity. Low sensitivity was based on low detection rate (32.6%) when compared nodes imaged by FDG-PET/CT to nodes found by surgery, and in inability to detect micrometastases. Sensitivity increased when also medium-large LNs were taken for positive, but specificity and accuracy decreased.
- 650 _2
- $a adenokarcinom $x farmakoterapie $x patologie $x chirurgie $7 D000230
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a adjuvantní chemoterapie $7 D017024
- 650 _2
- $a nádory jícnu $x farmakoterapie $x patologie $x chirurgie $7 D004938
- 650 _2
- $a gastroezofageální junkce $x patologie $7 D004943
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fluorodeoxyglukosa F18 $7 D019788
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfatické metastázy $x diagnostické zobrazování $x patologie $7 D008207
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neoadjuvantní terapie $7 D020360
- 650 _2
- $a staging nádorů $7 D009367
- 650 12
- $a PET/CT $7 D000072078
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a radiofarmaka $7 D019275
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bělohlávek, Otakar, $u PET Center, Hospital Na Homolce, Roentgenova 2, 150 30, Prague 5, Czech Republic. $d 1964- $7 ola2003188678
- 700 1_
- $a Haruštiak, Tomáš $u 3rd Clinic of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, V Uvalu 84, Praha 5, 150 06, Czech Republic. $7 xx0096527
- 700 1_
- $a Zemanová, Milada $u Clinic of Oncology, First Faculty of Medicine, Charles University in Prague and General Teaching Hospital, U Nemocnice 2, Praha 2, 128 08, Czech Republic. $7 xx0060597
- 773 0_
- $w MED00194920 $t Abdominal radiology $x 2366-0058 $g Roč. 41, č. 11 (2016), s. 2089-2094
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27405645 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20181213111814 $b ABA008
- 999 __
- $a ok $b bmc $g 1288605 $s 1007932
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 41 $c 11 $d 2089-2094 $i 2366-0058 $m Abdominal radiology $n Abdom Radiol (NY) $x MED00194920
- GRA __
- $a NT12331 $p MZ0
- LZP __
- $a Pubmed-20180404